Inflammatory bowel disease (IBD), which consists of Crohn's disease (CD) and ulcerative colitis (UC), is a chronic, inflammatory disorder of the gastro-intestinal tract with unknown etiology. Current evidence suggests that intestinal epithelial cells (IECs) is prominently linked to the pathogenesis of IBD. Therefore, maintaining the intact of epithelium has potential roles in improving pathophysiology and clinical outcomes of IBD. MicroRNAs (miRNAs) act as post-transcriptional gene regulators and regulate many biological processes, including embryonal development, cell differentiation, apoptosis and proliferation. In this study, we found that miR-200b decreased significantly in inflamed mucosa of IBD, especially for UC, when compared with their adjacent normal tissue. Simultaneously, we also found that the genes of E-cadherin and cyclin D1 were reduced significantly and correlated positively to the miR-200b. In addition, the upregulation of transforming growth factor-beta 1 (TGF-b1) was inversely correlated to the miR-200b in IBD. To investigate the possible roles of miR-200b in IECs maintaining, we used TGF-b1 to induce epithelial-mesenchymal transition (EMT) in IEC-6 initially. After sustained over-expressing miR-200b in IEC-6, the EMT was inhibited significantly that was characterized by downregulation of vimentin and upregulation of E-cadherin. Furthermore, we found that miR-200b enhanced E-cadherin expression through targeting of ZEB1, which encode transcriptional repressors of E-cadherin. SMAD2 was found to act as a target of miR-200b with direct evidence that miR-200b binding to the 3 0 UTR of SAMD2 and the ability of miR-200b to repress SMAD2 protein expression. With SMAD2 depletion, the expression of vimentin decreased correspondingly, which suggested miR-200b might reduce vimentin through regulating the SMAD2. With endogenous overexpression of miR-200b, the proliferation of IEC-6 cells increased significantly by increasing S-phase entry and promoting expression of the protein cyclin D1. Summarily, our study suggested a potential role for mir-200b in maintaining intact of intestinal epithelium through inhibiting EMT and promoting proliferation of IECs.
Inflammatory bowel disease (IBD), mainly referring to the Crohn's disease (CD) and ulcerative colitis (UC), is usually caused by a combination of genetic, immunological, bacterial and environmental factors. [1] [2] [3] [4] There is increasing evidence that loss of intestinal epithelial cells (IECs) acts as one of the major contributors to the pathogenesis of IBD. An intact monolayer of IECs, the largest areas that are exposed to and react with the external environment protects the body from pathogens and other toxic luminal substances. [5] [6] [7] [8] IBD patients often demonstrate increased intestinal paracellular permeability and decreased intestinal epithelial barrier function, which is mainly resulted from a loss of tight junction and epithelial cell loss. 6, [9] [10] [11] [12] Therefore, maintaining intact of epithelium is a potential strategy for IBD therapy.
The process of epithelial-mesenchymal transition (EMT) is characterized by losing epithelial cell marker such as E-cadherin, and gaining of a mesenchymal phenotype with expression of mesenchymal proteins including vimentin. 13, 14 Briefly, EMT allows a polarized epithelial cell, which normally interacts with basement membrane via its basal surface, to undergo multiple biochemical changes that enable it to a mesenchymal cell phenotype, which enhances migratory capacity, invasiveness and greatly increased production of cell-extracellular matrix components. 15 Recent studies demonstrated that EMT contributes to the pathogenesis of IBD, especially to the loss of IECs, based on the clinical analysis and animal experiments. 16, 17 Therefore, inhibiting EMT has potential roles in improving clinical outcomes of IBD.
MicroRNAs (miRNAs) are non-coding RNA molecules (21-23 nucleotides long) regulate gene expression at the post-transcriptional level by base pairing with specific sequences (miRNA response element) in the 3 0 UTR of target mRNAs causing degradation of mRNA or inhibition of translation. 18 The members of miR-200 family have been highlighted for its importance in the maintenance of the epithelial phenotype through repressing EMT by directly targeting and downregulating ZEB1 and ZEB2, resulting in enhanced E-cadherin expression. 19, 20 In the present study, we identify that downregulation of miR-200b expression is associated with loss of IECs in IBD. And then, we use a model of EMT to tackle the questions of whether and how miR-200b ameliorates intestinal epithelial barrier function in vitro.
Results
The miR-200b decreases in IBD. To investigate whether miR-200b participates in the pathogenesis of IBD, we performed real-time PCR to quantify the expression of miR200b in biopsy specimens of IBD initially. A total of 22 IBD patients (11 with CD and 11 with UC) have been enrolled in this study. Five patients with colonic polyps, which pathologically confirmed benign adenoma, served as non-IBD controls. The clinical features of subjects were showed in the Supplementary Table 1 . In patients with the active phase of IBD, the expression of miR-200b (175±90) was significantly lower (P ¼ 0.018) when compared with controls (261 ± 134). We further divided IBD into CD and UC and analyzed the expression of miR-200b in them. We found that the miR-200b decreased significantly in affected tissues compared with adjacent controls in UC patients (144 ± 72 versus 271±127, P ¼ 0.010). However, the expression of miR-200b in lesions and adjacent tissues has no significant difference in CD patients (206 ± 99 versus251 ± 146, P ¼ 0l.416). In the non-IBD controls, the expression of miR200b in the lesion did not differ from adjacent controls (228 ± 89 versus 243 ± 120, P ¼ 0.613) (Figure 1 ).
The downregulation of miR-200b correlates with the injury of IECs in IBD. IBD patients often have damages in IECs, which are linked to a disturbed intestinal homeostasis and barrier function. As we known, E-cadherin is required for the maintenance of architecture and function of the intestinal epithelium. In this study, the CDH1, gene of E-Cadherin, decreased significantly in the inflamed mucosa compared with adjacent normal control (28±67 versus 119±121, P ¼ 0.002). (Figure 2 ) In addition, immunohistochemistry analysis revealed that E-cadherin protein was also reduced significantly. (Supplementary Figure 1 and Supplementary  Table 1 (Figure 2 ). The balance of proliferation and death of IECs is another important factor to maintain the intestinal epithelium homeostasis. Here, we detected the expression of PCNA (proliferating cell nuclear antigen) and CCND1 in these IBD specimens with real-time PCR. PCNA is a marker of human colonic cell proliferation, and CCND1, encodes cyclin D1 that is required for cell cycle G1/S transition. 21 As shown in the Figure 3 , the mRNA of CCND1 reduced significantly in UC (0.18 ± 0.2 versus 0.89 ± 1.4, P ¼ 0.004), but not in CD (0.54±0.63 versus 0.70±0.86, P ¼ 0.291). In addition, CCND1 was correlated significantly with miR-200b. For expression of PCNA mRNA in IBD, there was no significant change could be found. (Figure 3) Enforced expression of the miR-200b prevents TGF-b1-induced EMT. EMT is a process characterized by loss of epithelial markers, gain of mesenchymal markers and changes in cellular morphology and phenotype with increased ability to migrate. The above findings suggested that EMT contributed to the injury of intestinal epithelial barrier in IBD. As an important inducer of EMT, TGF-b1 was detected and analyzed in these samples, and the correlation between TGF-b1 and miR-200b was also analyzed. As shown in Figure 3 , TGF-b1 increased significantly in both UC and CD lesions (UC, 12.5 ± 13.6 versus 5.6 ± 10.1, P ¼ 0.025; CD, 3.6 ± 4.3 versus 1.2 ± 1.8, P ¼ 0.004) and significantly correlated with miR-200b (R ¼ À0.36, P ¼ 0.03). In this study, we induced EMT in IEC-6 cells by exposure to 10 ng/ml human TGF-b1 as reported previously. 17 We showed that TGF-b1 treatment could lead IEC-6 cells to undergo EMT-like transformation evidenced by loss of cellcell adhesion and alterations of morphology from a round compact shape to a spindle shape. (Figure 4b ) Immunofluorescent labeling and western-blots demonstrated a phenotypic transition from an epithelial morphology toward mesenchymal-like properties evidenced by loss of the epithelial marker, E-cadherin and in turn increased expression of the mesenchymal marker, vimentin. With miR-200b over-expressed in IEC-6 cells, we observed that miR-200b could inhibit the process of EMT by increasing E-cadherin and decreasing vimentin. (Figure 5) TGF-b1 is a pleiotropic cytokine with important effects on a wide range of cells and processes, including wound healing/ tissue remodeling, being profibrotic, proangiogenic and antiproliferative. 22, 23 Typically, TGF-b1 affected genes expression through the SMAD transcription factors. Briefly, once TGF-b1 bind to its heterodimeric receptor I or II, the receptor phosphorylates SMAD2 and SMAD3, which then combine with SMAD4 and translocate to the nucleus to induce or repress the expression of several genes. 24 With using bioinformatics tool TargetScanHuman 6.2 (http://www. targetscan.org), miR-200b was predicted to target SMAD2 at position of 334-340 sites of its 3 0 UTR. The dual luciferase reporter assay showed miR-200b repressed the activity of luciferase significantly, which provided evidence of a direct link between miR-200b and human SMAD2 (Figure 6a ). We simultaneously demonstrated that the levels of phospho-SMAD2 were reduced because of miR-200b downregulation of total SMAD2 protein levels (Figure 6b ). After depletion of SMAD2 with RNA interference, we found that protein of vimentin was reduced correspondingly. ZEB1 was not only regarded as a transcriptional repressor of E-cadherin, but also of a direct target of miR-200b. [25] [26] [27] Here, we demonstrated that the expression of ZEB1 decreased significantly and resulted in upregulating of E-cadherin expression in miR-200b over-expressed cells. (Figure 6b) MiR-200b promotes proliferation of IECs. The intestinal epithelium is a dynamic tissue characterized by a high rate of cell death and reproduction, leading to renewal of the entire intestinal epithelium every 3-5 days. 28 Patients with IBD have been demonstrated increased apoptosis of the acute inflammatory sites throughout the entire crypt-villus axis. 29, 30 Sartor et al. 24 reported that aberrant of immune activation and overproduction of inflammatory cytokines induced death of intestinal epithelial cells in IBD. Therefore, promoting IEC proliferation was necessary to replenish the decreased cell pool and further to ameliorate epithelial barrier function. Here, we demonstrated that proliferation of IEC-6 was (Figure 7a ) With flow cytometry analysis, we observed that the over-expression of miR-200b altered the cell cycle by increasing S-phase and decreasing G1 phase significantly. Moreover, we found that the cyclin D1 protein expression was promoted by miR-200b over-expression. (Figures 7b and c) 
Discussion
Currently, it remained unclear about the etiology and pathogenesis of IBD. Evidences from the animals and human have been demonstrated that loss of IECs contributed to the tissue damage and the severity of colonic inflammatory response. Therefore, maintaining intact of epithelium may provide novel and effective strategies to treat IBD. 31 At the center of intestinal barrier, IECs, has an active role in producing mucus and providing a physical barrier capable of controlling antigen traffic through the intestinal mucosa. Injuries/defects of IECs have been shown to increase epithelial permeability in IBD, which has been shown to possibly caused relapse. [32] [33] [34] The EMT, characterized by losing of epithelial markers and the acquisition of mesenchymal morphological markers, has aroused extensive interest in IBD research recently. 17, 35, 36 The EMT contributes to the disassembly of tight junctions and loss of apical-basal polarity in IECs due to a repression of the transmembrane adhesion receptor E-cadherin and a gain in expression of the mesenchymal features. The gene of E-cadherin (CDH1) has been reported to be associated with pathogenesis of IBD, with patients possessing the diseaseassociated single nucleotide polymorphisms having increased E-cadherin cytoplasmic accumulation. 37 In this study, we found that the expression of E-cadherin decreased in the inflamed mucosa of IBD compared with the adjacent controls at both mRNA and protein levels. On the contrary, the expression of vimentin mRNA increased significantly. (Figure 2 and Supplementary Figure 1 38 Here, dual-luciferase and western-blot analysis provided direct evidence that miR-200b binded to 3 0 UTR of SMAD2 hence repressed SMAD2 protein expression in IEC-6 cells. As one important mediator in TGF-b1 signaling, SMAD2 was involved in TGF-b1-mediated EMT. [39] [40] [41] In this study, we found that expression of vimentin was decreased correspondingly after SMAD2 knocked down ( Figure 6 ). It suggested that miR-200b might inhibit expression of vimentin through TGF-b1-SMAD2 signal pathway.
The intestinal epithelium is a dynamic tissue characterized by renewal of the entire intestinal epithelium every 3-5 days in mice. 28 A balance between cellular proliferation and death is necessary to maintain the normal function of IECs. We found that the CCND1, gene of Cyclin D1, was decreased significantly in IBD, and positively related to the miR-200b in these specimens. (Figure 3 Immunohistochemistry and immunofluorescence assay. Immunohistochemistry was performed using method of diaminobenzidine (DAB) chromogen as described previously. 35 Briefly, tissue samples were incubated with xylol and descending concentrations of ethanol. Antigen retrieval was performed using citrate buffer, pH 6.0 (microwave treatment, 40 min at 240 W). Endogenous peroxidases were removed by incubation with 0.3% H 2 O 2 for 15 min at room temperature (RT) and blocking was performed using 5% bovine serum albumin (BSA) for 1 h at RT. Primary antibodies were then applied in an optimal concentration overnight in a wet chamber. (N-cadherin, dilution 1:200; E-cadherin, dilution 1:200; vimentin dilution 1:100). After incubation for 30 min at 37 1C following overnight at 4 1C, the slides were rinsed in phosphate-buffered saline (PBS) and incubated with the secondary antibody for 1 h at RT. Antibody binding was visualized by a liquid DAB Substrate Chromogen System (Dako, Glostrup, Denmark). The slides were rinsed in PBS and counterstained with hematoxylin. The evaluation of immunohistochemical pattern was performed in blinded fashion by a pathologist (M, Z) experienced in IBD. For immunofluorescence analysis, the cells were fixed with 4% paraformaldehyde initially. After blocking cell with 3% BSA for half an hour at RT, the cells were incubated with the anti-E-cadherin antibody or anti-Vimentin antibody at RT for 2 h. After washing three times with PBS, the second antibody conjugated with FITC was performed on these cells for 1 h at RT. The nuclei were counterstained with DAPI.
Cell culture and lentivirus production. The small intestinal cell line IEC-6 was grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS).
Lentivirus infection was commenced when the IEC-6 cells were either at 40-60% confluence. The EMT was induced by conditioned medium DMEM supplemented with 0.5% FBS containing TGF-b1 (10 ng/ml) as described previously. 43 For constructing the miR-200b-lentivirus, the sequence of miR-200b precursor was inserted into pGCSIL vector with enzymes Age I/ EcoR I. The combined plasmid was transfected into 293T cells. After 48 h, the supernatant was collected by centrifugation at 4000 r.p.m. for 10 min. The debris were removed by filtering with 0.45 mm filter. The titer of lentiviral vectors was determined by fluorescenceactivated cell sorting.
Real-time PCR. The total RNA was extracted from the cells or tissues with Trizol (Invitrogen, Carlsbad, CA, USA) according to the protocol of manufacture. For determining the expression of miR-200b, miR-200b was reverse transcribed and quantified with a TaqMan microRNA assays (Applied Biosystems). All data were normalized to U6. For genes assay, SYBR-Green Universal Master Mix kit and High Capacity cDNA Reverse Transcription kit (Applied Biosystems) were employed to detect the levels of these genes. All reactions were repeated three times and GAPDH was used to normalize the target genes. The PCR Western blots. Western blots were performed using standard procedures. Briefly, protein of 30 mg/well was separated on 4-12% SDS-polyacrylamide gels and transferred onto nitrocellulose using a dry blotting system (iBLOT system, Invitrogen). After blocking in PBS, 5% nonfat milk at RT for 30 min, membranes were incubated with the primary antibodies overnight at 4 1C. The primary antibodies of E-cadherin, Vimentin, SMAD2, ZEB1 and cyclin D1 were performed in this study. The membranes were washed three times with PBS and 0.1% Tween-20, and then incubated with secondary antibodies. After final washes with PBS and 0.1% Tween-20, the signals were detected using ECL chemiluminescence reagents. (Pierce, Rockford, IL, USA).
Flow cytometric and proliferative analysis. Cells were seeded in 96-well plates with 30-50% confluence initially. The proliferation of IEC-6 cells was analyzed using the Cell Counting Kit-8 (Dojindo) after 24 or 48 h. The absorbance value of each well was determined at 450 nm by a microplate reader (Beckman Coulter Instruments, Brea, CA, USA). IEC-6 cells were fixed with ice-cold 70% ethanol, labeled with PI, and cell cycle was detected by flow cytometry as described before. 44 Luciferase reporter assay. The 3 0 -UTR for SMAD2 was amplified from genomic DNA. Amplified 3 0 UTRs were cloned to the downstream of luciferase coding region in the pGL3 vector (Promega, Madison, WI, USA). 400 ng pGL-SMAD2 plasmids were transfected into IEC-6 cells with lentiviral-vector/lentiviralmiR-200b infection by using Lipofectamine-2000 (Invitrogen, Inc). Cells were harvested for luciferase activity assays 48 h after transfection. The relative reporter activity was obtained by normalization to the Renilla control luciferase activity.
Statistical analysis. All data are reported as mean ±S.D. When comparisons were made between two different groups, statistical significance was determined by the Student's t-test using SPSS19 software program. P values from a two-tailed test were o0.05 were considered statistically significant. Pearson correlation and linear regression analysis were used to assess correlation between miR-200b and CDH1, Vimentin, TGF-b1, CCND1 and PCNA.
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